ASU Scholarship Showcase

The estimation of energy demand (by power plants) has traditionally relied on historical energy use data for the region(s) that a plant produces for. Regression analysis, artificial neural network and Bayesian theory are the most common approaches for analysing these data. Such data and techniques do not generate reliable results. Consequently, excess energy has to be generated to prevent blackout; causes for energy surge are not easily determined; and potential energy use reduction from energy efficiency solutions is usually not translated into actual energy use reduction. The paper highlights the weaknesses of traditional techniques, and lays out a framework to improve the prediction of energy demand by combining energy use models of equipment, physical systems and buildings, with the proposed data mining algorithms for reverse engineering. The research team first analyses data samples from large complex energy data, and then, presents a set of computationally efficient data mining algorithms for reverse engineering. In order to develop a structural system model for reverse engineering, two focus groups are developed that has direct relation with cause and effect variables. The research findings of this paper includes testing out different sets of reverse engineering algorithms, understand their output patterns and modify algorithms to elevate accuracy of the outputs.

Small and medium office buildings consume a significant parcel of the U.S. building stock energy consumption. Still, owners lack resources and experience to conduct detailed energy audits and retrofit analysis. We present an eight-steps framework for an energy retrofit assessment in small and medium office buildings. Through a bottom-up approach and a web-based retrofit toolkit tested on a case study in Arizona, this methodology was able to save about 50% of the total energy consumed by the case study building, depending on the adopted measures and invested capital. While the case study presented is a deep energy retrofit, the proposed framework is effective in guiding the decision-making process that precedes any energy retrofit, deep or light.

Commercial buildings’ consumption is driven by multiple factors that include occupancy, system and equipment efficiency, thermal heat transfer, equipment plug loads, maintenance and operational procedures, and outdoor and indoor temperatures. A modern building energy system can be viewed as a complex dynamical system that is interconnected and influenced by external and internal factors. Modern large scale sensor measures some physical signals to monitor real-time system behaviors. Such data has the potentials to detect anomalies, identify consumption patterns, and analyze peak loads. The paper proposes a novel method to detect hidden anomalies in commercial building energy consumption system. The framework is based on Hilbert-Huang transform and instantaneous frequency analysis. The objectives are to develop an automated data pre-processing system that can detect anomalies and provide solutions with real-time consumption database using Ensemble Empirical Mode Decomposition (EEMD) method. The finding of this paper will also include the comparisons of Empirical mode decomposition and Ensemble empirical mode decomposition of three important type of institutional buildings.

There are an increasing variety of applications in which peptides are both synthesized and used attached to solid surfaces. This has created a need for high throughput sequence analysis directly on surfaces. However, common sequencing approaches that can be adapted to surface bound peptides lack the throughput often needed in library-based applications. Here we describe a simple approach for sequence analysis directly on solid surfaces that is both high speed and high throughput, utilizing equipment available in most protein analysis facilities. In this approach, surface bound peptides, selectively labeled at their N-termini with a positive charge-bearing group, are subjected to controlled degradation in ammonia gas, resulting in a set of fragments differing by a single amino acid that remain spatially confined on the surface they were bound to. These fragments can then be analyzed by MALDI mass spectrometry, and the peptide sequences read directly from the resulting spectra.

There are many data mining and machine learning techniques to manage large sets of complex energy supply and demand data for building, organization and city. As the amount of data continues to grow, new data analysis methods are needed to address the increasing complexity. Using data from the energy loss between the supply (energy production sources) and demand (buildings and cities consumption), this paper proposes a Semi-Supervised Energy Model (SSEM) to analyse different loss factors for a building cluster. This is done by deep machine learning by training machines to semi-supervise the learning, understanding and manage the process of energy losses. Semi-Supervised Energy Model (SSEM) aims at understanding the demand-supply characteristics of a building cluster and utilizes the confident unlabelled data (loss factors) using deep machine learning techniques. The research findings involves sample data from one of the university campuses and presents the output, which provides an estimate of losses that can be reduced. The paper also provides a list of loss factors that contributes to the total losses and suggests a threshold value for each loss factor, which is determined through real time experiments. The conclusion of this paper provides a proposed energy model that can provide accurate numbers on energy demand, which in turn helps the suppliers to adopt such a model to optimize their supply strategies.

Recent infectious outbreaks highlight the need for platform technologies that can be quickly deployed to develop therapeutics needed to contain the outbreak. We present a simple concept for rapid development of new antimicrobials. The goal was to produce in as little as one week thousands of doses of an intervention for a new pathogen. We tested the feasibility of a system based on antimicrobial synbodies. The system involves creating an array of 100 peptides that have been selected for broad capability to bind and/or kill viruses and bacteria. The peptides are pre-screened for low cell toxicity prior to large scale synthesis. Any pathogen is then assayed on the chip to find peptides that bind or kill it. Peptides are combined in pairs as synbodies and further screened for activity and toxicity. The lead synbody can be quickly produced in large scale, with completion of the entire process in one week.

Antigen-antibody complexes are central players in an effective immune response. However, finding those interactions relevant to a particular disease state can be arduous. Nonetheless many paths to discovery have been explored since deciphering these interactions can greatly facilitate the development of new diagnostics, therapeutics, and vaccines. In silico B cell epitope mapping approaches have been widely pursued, though success has not been consistent. Antibody mixtures in immune sera have been used as handles for biologically relevant antigens, but these and other experimental approaches have proven resource intensive and time consuming. In addition, these methods are often tailored to individual diseases or a specific proteome, rather than providing a universal platform. Most of these methods are not able to identify the specific antibody’s epitopes from unknown antigens, such as un-annotated neo antigens in cancer. Alternatively, a peptide library comprised of sequences unrestricted by naturally-found protein space provides for a universal search for mimotopes of an antibody’s epitope. Here we present the utility of such a non-natural random sequence library of 10,000 peptides physically addressed on a microarray for mimotope discovery without sequence information of the specific antigen. The peptide arrays were probed with serum from an antigen-immunized rabbit, or alternatively probed with serum pre-absorbed with the same immunizing antigen. With this positive and negative screening scheme, we identified the library-peptides as the mimotopes of the antigen. The unique library peptides were successfully used to isolate antigen-specific antibodies from complete immune serum. Sequence analysis of these peptides revealed the epitopes in the immunized antigen. We present this method as an inexpensive, efficient method for identifying mimotopes of any antibody’s targets. These mimotopes should be useful in defining both components of the antigen-antibody complex.

Immunosignaturing shows promise as a general approach to diagnosis. It has been shown to detect immunological signs of infection early during the course of disease and to distinguish Alzheimer’s disease from healthy controls. Here we test whether immunosignatures correspond to clinical classifications of disease using samples from people with brain tumors. Blood samples from patients undergoing craniotomies for therapeutically naïve brain tumors with diagnoses of astrocytoma (23 samples), Glioblastoma multiforme (22 samples), mixed oligodendroglioma/astrocytoma (16 samples), oligodendroglioma (18 samples), and 34 otherwise healthy controls were tested by immunosignature. Because samples were taken prior to adjuvant therapy, they are unlikely to be perturbed by non-cancer related affects. The immunosignaturing platform distinguished not only brain cancer from controls, but also pathologically important features about the tumor including type, grade, and the presence or absence of O⁶-methyl-guanine-DNA methyltransferase methylation promoter (MGMT), an important biomarker that predicts response to temozolomide in Glioblastoma multiformae patients.

Background: The success of new sequencing technologies and informatic methods for identifying genes has made establishing gene product function a critical rate limiting step in progressing the molecular sciences. We present a method to functionally mine genomes for useful activities in vivo, using an unusual property of a member of the poxvirus family to demonstrate this screening approach.

Results: The genome of Parapoxvirus ovis (Orf virus) was sequenced, annotated, and then used to PCR-amplify its open-reading-frames. Employing a cloning-independent protocol, a viral expression-library was rapidly built and arrayed into sub-library pools. These were directly delivered into mice as expressible cassettes and assayed for an immune-modulating activity associated with parapoxvirus infection. The product of the B2L gene, a homolog of vaccinia F13L, was identified as the factor eliciting immune cell accumulation at sites of skin inoculation. Administration of purified B2 protein also elicited immune cell accumulation activity, and additionally was found to serve as an adjuvant for antigen-specific responses. Co-delivery of the B2L gene with an influenza gene-vaccine significantly improved protection in mice. Furthermore, delivery of the B2L expression construct, without antigen, non-specifically reduced tumor growth in murine models of cancer.

Conclusion: A streamlined, functional approach to genome-wide screening of a biological activity in vivo is presented. Its application to screening in mice for an immune activity elicited by the pathogen genome of Parapoxvirus ovis yielded a novel immunomodulator. In this inverted discovery method, it was possible to identify the adjuvant responsible for a function of interest prior to a mechanistic study of the adjuvant. The non-specific immune activity of this modulator, B2, is similar to that associated with administration of inactivated particles to a host or to a live viral infection. Administration of B2 may provide the opportunity to significantly impact host immunity while being itself only weakly recognized. The functional genomics method used to pinpoint B2 within an ORFeome may be more broadly applicable to screening for other biological activities in an animal.

Background: Immunosignaturing is a new peptide microarray based technology for profiling of humoral immune responses. Despite new challenges, immunosignaturing gives us the opportunity to explore new and fundamentally different research questions. In addition to classifying samples based on disease status, the complex patterns and latent factors underlying immunosignatures, which we attempt to model, may have a diverse range of applications.

Methods: We investigate the utility of a number of statistical methods to determine model performance and address challenges inherent in analyzing immunosignatures. Some of these methods include exploratory and confirmatory factor analyses, classical significance testing, structural equation and mixture modeling.

Results: We demonstrate an ability to classify samples based on disease status and show that immunosignaturing is a very promising technology for screening and presymptomatic screening of disease. In addition, we are able to model complex patterns and latent factors underlying immunosignatures. These latent factors may serve as biomarkers for disease and may play a key role in a bioinformatic method for antibody discovery.

Conclusion: Based on this research, we lay out an analytic framework illustrating how immunosignatures may be useful as a general method for screening and presymptomatic screening of disease as well as antibody discovery.